ARCHEAN CHEMICAL IND LTD

Archean Chemical Industries Limited held its Q1 FY27 earnings conference call on August 3, 2026, where management discussed the company's financial performance and operational highlights. Management reported standalone revenue of INR3,321 million, a 14% year-on-year increase, and EBITDA of INR838.7 million, reflecting a 26.3% sequential rise. Profit after tax on a standalone basis was INR405.3 million, up 36% sequentially. Key drivers included strong bromine volumes and a positive EBITDA from the Acume derivatives business. However, logistics challenges, particularly in industrial salt, impacted profitability. Management noted that while logistics costs had increased, they anticipated normalization following infrastructure improvements. The company also highlighted ongoing trials for Sulphate of Potash and progress in its semiconductor project. Overall, management expressed confidence in maintaining momentum into the second half of FY27, focusing on core business consolidation and scaling up derivatives.

Management highlighted both positive financial results and ongoing challenges in logistics.